UniXell Biotechnology

Shanghai, China · Founded 2021 · Privately Held (backing)

Developer of cellular therapy designed for human pluripotent stem cells. UniXell Biotechnology is based in Shanghai, China and was founded in 2021. It has raised $66.6 million.

Last price · $/share

—

Implied valuation

—

Total raised

$66.6M

Last round

—

How much has UniXell Biotechnology raised?

$66.6Macross 0 recorded rounds

Free account

More of UniXell Biotechnology with a free account

·The complete investor list: 21 names
·Watch UniXell Biotechnology: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

UniXell Biotechnology investors

21 investors are on record for UniXell Biotechnology, including GL Ventures, CDH Investments, Tencent Investment and Pudong Capital.

For fundraisers

Raising for a company like UniXell Biotechnology?

21 investors have backed UniXell Biotechnology.

See all 21 investors →

Frequently asked about UniXell Biotechnology

How much has UniXell Biotechnology raised?: UniXell Biotechnology has raised $66.6M in total across 0 recorded funding rounds.